These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18525317)

  • 1. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
    Gupta V; Singh SM
    Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma.
    Gupta V; Singh SM
    J Reprod Immunol; 2007 Jun; 74(1-2):90-102. PubMed ID: 17275917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
    Singh V; Singh SM
    Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin promotes growth of a spontaneous T cell lymphoma: role of tumor and host derived cytokines.
    Singh MP; Sharma H; Singh SM
    Cancer Invest; 2006 Oct; 24(6):601-10. PubMed ID: 16982465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender dimorphism of tumor growth: role of gonadal hormones in differential regulation of apoptosis of a murine T cell lymphoma.
    Gupta V; Singh SM
    J Biomed Sci; 2008 Mar; 15(2):147-62. PubMed ID: 17965948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells.
    Gupta V; Singh SM
    Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumour stage-dependent evolution of drug resistant T cell lymphoma: role of soluble mediators of tumour and host origin.
    Singh V; Singh SM
    Leuk Res; 2009 May; 33(5):700-9. PubMed ID: 18930317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
    Shanker A; Singh SM
    Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host.
    Kumar A; Vishvakarma NK; Bharti AC; Singh SM
    Blood Cells Mol Dis; 2012 Feb; 48(2):137-44. PubMed ID: 22104368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender dimorphism in the progressive in vivo growth of a T cell lymphoma: involvement of cytokines and gonadal hormones.
    Singh MP; Rai AK; Singh SM
    J Reprod Immunol; 2005 Feb; 65(1):17-32. PubMed ID: 15694964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender variation in interleukin-13 production: a possible mechanism of differential in vivo growth of a T-cell lymphoma.
    Deepak P; Kumar S; Acharya A
    Scand J Immunol; 2008 Jun; 67(6):581-8. PubMed ID: 18397198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival.
    Kumar A; Vishvakarma NK; Tyagi A; Bharti AC; Singh SM
    Biosci Rep; 2012 Feb; 32(1):91-104. PubMed ID: 21692746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-13 Ralpha2-mediated interleukin-13 neutralization represses in vivo progressive growth of a T-cell lymphoma.
    Deepak P; Sanjay K; Acharya A
    J Exp Clin Cancer Res; 2007 Sep; 26(3):347-52. PubMed ID: 17987794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole.
    Vishvakarma NK; Singh SM
    Biochimie; 2011 Oct; 93(10):1786-96. PubMed ID: 21722701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
    Prasad SB; Giri A; Arjun J
    Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
    Sarna S; Bhola RK
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.
    Teicher BA; Ikebe M; Ara G; Keyes SR; Herbst RS
    In Vivo; 1997; 11(6):463-72. PubMed ID: 9509296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A; Kant S; Singh SM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation.
    Kumar A; Kant S; Singh SM
    Chem Biol Interact; 2012 Jul; 199(1):29-37. PubMed ID: 22705712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.